CVS Group’s (CVSG) Buy Rating Reiterated at Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of CVS Group (LON:CVSG) in a report issued on Thursday, MarketBeat reports. The firm currently has a GBX 2,000 target price on the stock.

A number of other equities analysts have also issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,700 price target on shares of CVS Group in a report on Monday, July 27th. Jefferies Financial Group upped their price objective on CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a research note on Friday, July 31st. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of GBX 1,666.67.

CVS Group Stock Down 1.1%

Shares of LON:CVSG opened at GBX 1,208 on Thursday. CVS Group has a 1-year low of GBX 1,062 and a 1-year high of GBX 1,648. The company has a debt-to-equity ratio of 110.41, a current ratio of 1.18 and a quick ratio of 0.90. The stock has a market cap of £821.08 million, a P/E ratio of 17.53, a P/E/G ratio of 1.77 and a beta of 1.07. The firm has a fifty day moving average price of GBX 1,287.09 and a 200 day moving average price of GBX 1,229.43.

CVS Group (LON:CVSG) last posted its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 EPS for the quarter. CVS Group had a net margin of 2.43% and a return on equity of 5.91%. Sell-side analysts predict that CVS Group will post 93.9393939 EPS for the current year.

Insider Transactions at CVS Group

In other CVS Group news, insider Robin Alfonso purchased 768 shares of CVS Group stock in a transaction dated Thursday, August 6th. The stock was acquired at an average cost of GBX 1,294 per share, with a total value of £9,937.92. Also, insider Joanne Shaw purchased 1,592 shares of CVS Group stock in a transaction dated Monday, August 10th. The stock was acquired at an average cost of GBX 1,287 per share, with a total value of £20,489.04. In the last three months, insiders acquired 3,860 shares of company stock valued at $4,956,696. Corporate insiders own 1.48% of the company’s stock.

More CVS Group News

Here are the key news stories impacting CVS Group this week:

• Positive Sentiment: Dividend supported by shareholder returns: CVS Group recommended a final dividend for the year ended June 30, 2026, payable on December 4, providing an income component for investors. CVS Group recommends final dividend
• Positive Sentiment: Insider purchase offers a modest confidence signal: Non-executive director Laura Hagan bought 4,128 CVS Group shares. The transaction may reassure investors about management’s view of the company’s valuation, although its financial impact is limited. CVS Group director share purchase
• Positive Sentiment: Berenberg maintained a Buy rating and a GBX 2,000 price target, implying substantial upside from the stock’s recent trading level. Berenberg rating update
• Neutral Sentiment: Full-year results were released: CVS Group reported GBX 85.60 in earnings per share, alongside a 2.31% net margin and 5.35% return on equity. The figures provide a fresh performance update, but the relatively low profitability metrics may limit enthusiasm without further detail on growth and costs. CVS Group full-year earnings results
• Negative Sentiment: Analyst caution remains the main pressure: Shore Capital reaffirmed its Hold rating and GBX 1,400 target, while Jefferies also maintained Hold with the same target. The repeated neutral recommendations suggest limited near-term conviction despite the higher Berenberg target. Shore Capital Hold rating

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.